Skip to Main Content

Advertisement

Skip Nav Destination

Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion1

Cancer Res (1991) 51 (4): 1105–1108.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal